Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by FarmerBetsyon Jul 28, 2023 9:26am
174 Views
Post# 35561254

RE:How low will it go?

RE:How low will it go?BottomBroker, the share price will go where the Boston group wants to put it. Remember very few people know about this closely held company. They have had by design no promotion, anlalyst following, social media etc.. I have in the past referred to Friday April 28th when we were on the upswing then obvious share downturn that day caused by? More recently out of the tsx to consolidate reasons quoted "delisting from the tsx will lower expenditures of a dual listing and provide savings in time and effort of management, which can be directed to initiatives intended to generate shareholder value." Only if i could post a CARTOON of charactors laughing, they continue to mislead with information and suppress it. They got rid of the tsx for totally different reasons not reported!

Ask your self and answer how does the Nasdaq before tsx consolidation trading daily with numbers of 4,436, 10,760, 14,859 jump to 13,926,020? When Promis has about 8,500,000 shares outstanding on the market? How many people do you know in this stock have the power to do that? My guess a whole lot of moving been brokerage houses, nevertheless Gail, the Boston group and closely held insiders are contolling where the price goes.

<< Previous
Bullboard Posts
Next >>